We are live on
!
Find out more
MCP
Martin Capital Partners Portfolio holdings
AUM
$272M
1-Year Est. Return
19.09%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+19.09%
3 Year Est. Return
+35.19%
5 Year Est. Return
+47.96%
10 Year Est. Return
–
AUM
$261M
AUM Growth
+$15.4M
(+6.3%)
Cap. Flow
+$3.88M
Cap. Flow
% of AUM
1.49%
Top 10 Holdings %
Top 10 Hldgs %
29.74%
Holding
72
New
2
Increased
16
Reduced
45
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hershey
HSY
|
+$4.54M |
| 2 |
Realty Income
O
|
+$4.28M |
| 3 |
Pfizer
PFE
|
+$2.68M |
| 4 |
Skyworks Solutions
SWKS
|
+$1.08M |
| 5 |
T. Rowe Price
TROW
|
+$780K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.33M |
| 2 |
JPMorgan Chase
JPM
|
+$2.97M |
| 3 |
State Street SPDR S&P Dividend ETF
SDY
|
+$2.37M |
| 4 |
Amgen
AMGN
|
+$252K |
| 5 |
US Bancorp
USB
|
+$210K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.69% |
| 2 | Consumer Staples | 15.16% |
| 3 | Industrials | 14.98% |
| 4 | Technology | 10.52% |
| 5 | Energy | 9.94% |
Similar funds
SC
SC
BLAM
TP
AGP
SFPG
S
SS
Martin Capital Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Martin Capital Partners held 72 positions worth $261M, up 6.3% from $245M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Martin Capital Partners's Q1 2024 filing shows 2 new, 16 increased, 45 reduced and 3 closed positions. Its largest new stake was Hershey: 23,510 shares worth $4.57M. The largest sale was Gilead Sciences, an estimated $3.33M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Consumer Staples and Industrials.
- Martin Capital Partners's largest Q1 2024 buy was Hershey: 23,510 shares worth $4.57M.
- Martin Capital Partners added most to Pfizer in Q1 2024, an estimated $2.68M increase.
- Martin Capital Partners's biggest Q1 2024 reduction was JPMorgan Chase, cutting an estimated $2.97M.
- Martin Capital Partners fully exited Gilead Sciences in Q1 2024, selling an estimated $3.33M.
- Martin Capital Partners's ten largest holdings make up 30% of its $261M portfolio in Q1 2024.
- Martin Capital Partners opened 2 new positions and closed 3 in Q1 2024.
- Martin Capital Partners's portfolio value rose 6.3% quarter-over-quarter to $261M.
Based on Martin Capital Partners's 13F filing for Q1 2024, filed 5 Apr 2024.